Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3770907013 | Certolizumab pegol only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3770908015 | Product containing only certolizumab pegol in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Certolizumab pegol only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Certolizumab pegol only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
Certolizumab pegol only product in parenteral dose form | Is a | Certolizumab pegol only product | true | Inferred relationship | Some | ||
Certolizumab pegol only product in parenteral dose form | Is a | Certolizumab pegol-containing product in parenteral dose form | true | Inferred relationship | Some | ||
Certolizumab pegol only product in parenteral dose form | Has active ingredient | Certolizumab pegol | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Certolizumab pegol 200 mg powder for solution for injection vial | Is a | True | Certolizumab pegol only product in parenteral dose form | Inferred relationship | Some | |
Certolizumab pegol 200 mg/mL solution for injection | Is a | True | Certolizumab pegol only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets